title: [Treatment-resistant depressions in borderline psychiatry].
abstract: We studied the efficacy of venlafaxine in treatment-resistant depressions of the borderline level. Thirty patients, aged from 23 to 63 years, with non-psychotic depressions were examined. Due to the absence of the effect of the previous treatment, they were treated with venlafaxine in dosage 75-150 mg/day during 35 weeks. The positive response was seen in 19 (63,7%) patients. The drug was well-tolerated.
  
  
  CONCLUSIONS
  venlafaxine may be used as an affective medication in treatment-resistant non-psychotic depressions.
authors.forename: D V
authors.initials: DV
authors.lastname: Iastrebov
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride; D055815:Young Adult
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride